TipRanks
Go Ultimate55% OFF

Provexis (PXS) Share Price & Analysis

2 Followers

PXS Stock Chart & Stats

GBX 0.86GBX 0.00(0.00%)
At close: 4:30 PM GMT
0.8 p0.9 p1 p1.1 pAug 10Aug 24Sep 7Sep 21Oct 5Oct 19Nov 2
Day’s Range
GBX 0.74 - GBX 0.93
52-Week Range
GBX 0.55 - GBX 1.55
Previous Close
GBX 0.86
Volume
N/A
Average Volume (3M)
543.60K
Market Cap
GBP 20.06M
Enterprise Value
GBP 23.79M
Total Cash (Recent Filing)
GBP 893.14K
Total Debt (Recent Filing)
GBP 0
Price to Earnings (P/E)
―
Beta
-0.08
Next Earnings
Dec 18, 2026 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Revenue Growth

A 45.1% year-on-year revenue increase shows stronger commercial scale and demand for the company's offerings. If growth persists, it can broaden the revenue base and provide operating leverage, although current evidence does not yet establish that profitability will follow.

Debt-Free Balance Sheet

No reported debt across all periods limits refinancing pressure and interest-related financial risk. This conservative structure preserves flexibility to direct future resources toward product commercialisation and operations, while reducing vulnerability if losses continue.

Improved Cash Generation

Positive operating cash flow and roughly £180k of free cash flow in 2026 mark a meaningful improvement from negative free cash flow in 2025. Sustained conversion of revenue into cash would strengthen self-funding capacity and reduce reliance on external capital.

Bears Say

Persistent Losses

Continued operating and net losses, alongside a net margin near -40%, show that recent revenue expansion has not translated into viable earnings. Persistent losses can consume resources and make the route to breakeven dependent on material margin improvement.

Declining Equity And Negative ROE

Equity declined from 2025 to 2026 while 2026 ROE was roughly -45%, indicating that shareholder capital is not currently generating returns. Further losses could erode the balance-sheet cushion and reduce flexibility to fund growth without improvement.

Volatile Cash Flow

Cash generation remains unproven: the company has recorded repeated cash burn, and the 2026 free-cash-flow improvement is described as volatile. Without sustained positive cash flow, funding operations and commercial expansion may remain difficult despite the debt-free balance sheet.

Provexis News

PXS FAQ

What was Provexis’s price range in the past 12 months?
Provexis lowest share price was 0.55 p and its highest was 1.55 p in the past 12 months.
What is Provexis’s market cap?
Provexis’s market cap is £20.06M.
When is Provexis’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Provexis’s earnings last quarter?
Provexis released its earnings results on Sep 30, 2026. The company reported 0 p earnings per share for the quarter.
Is Provexis overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Provexis pay dividends?
Provexis does not currently pay dividends.
What is Provexis’s EPS estimate?
Provexis’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Provexis have?
Provexis has 2,345,891,400 shares outstanding.
What happened to Provexis’s price movement after its last earnings report?
Provexis reported an EPS of 0 p in its last earnings report. Following the earnings report the stock price went up 5.714%.
Which hedge fund is a major shareholder of Provexis?
Currently, no hedge funds are holding shares in GB:PXS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology